COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,138 Articles (21,585 medRxiv, 7,553 bioRxiv)

Most recent first Previous |  Page 409: Articles 4081-4090  | Next

Comparison Of New and emerging SARS-CoV-2 variant Transmissibility through Active Contact Testing. A comparative cross-sectional household seroprevalence study.
Gaskell, K. M., El Kheir, N., Mirfenderesky, M., Rampling, T., Marks, M., Houlihan, C., Lemonge, N., Bristowe, H., Aslam, S., Kyprianou, D., Nastouli, E., Goldblatt, D., Fielding, K., Moore, D., CONTACT study team
10.1101/2022.09.27.22280419 — Posted: 2022-09-27
Presentation of long COVID and associated risk factors in a mobile health study
Stewart, C., Ranjan, Y., Conde, P., Sun, S., Rashid, Z., Sankesara, H., Cummins, N., Laiou, P., Bai, X., Dobson, R., Folarin, A.
10.1101/2022.09.27.22280404 — Posted: 2022-09-27
Evaluation of health system resilience in 60 countries based on their responses to COVID-19
Zhao, L., Jin, Y., Zhou, L., Yang, P., Qian, Y., Huang, X., Min, M.
10.1101/2022.09.25.22280337 — Posted: 2022-09-27
Emergence and Persistent Dominance of Omicron BA.2.3.7 Variant in Community Outbreaks in Taiwan
Shai, P.-L., Tu, H.-C., Gong, Y.-N., Shu, H.-Y., Kirby, R., HSU, L.-Y., YEO, H.-Y., Kuo, H.-Y., Huang, Y.-C., Lin, Y.-F., Weng, H.-Y., wu, y.-l., Chen, C.-C., Chen, T.-W., Lee, K.-M., Huang, C.-G., Shih, S.-R., Chen, W.-J., Wu, C.-C., Yu, C.-J., Tsai, S.-F.
10.1101/2022.09.27.22280238 — Posted: 2022-09-27
Direct modelling from GPS data reveals daily-activity-dependency of effective reproduction number in COVID-19 pandemic
Ozaki, J., Shida, Y., Takayasu, H., Takayasu, M.
10.1101/2022.09.27.22280400 — Posted: 2022-09-27
Long-term mental health outcomes after SARS-CoV-2 infection: prospective cohort study
Wang, Y., Xie, J., CLEMENTE, G., PRIETO-ALHAMBRA, D.
10.1101/2022.09.26.22280293 — Posted: 2022-09-27
Evaluation of S/F94 as a proxy for COVID-19 severity
Swets, M. C., Kerr, S., Scott-Brown, J., Brown, A. B., Gupta, R. K., Millar, J. E., Spata, E., McCurrach, F., Bretherick, A. D., Docherty, A. B., Harrison, D., Rowan, K., Young, N., ISARIC4C, , Groeneveld, G. H., Dunning, J., Nguyen-Van-Tam, J. S., Openshaw, P. J., Horby, P. W., Harrison, E. M., Staplin, N., Semple, M. G., Lone, N., Baillie, J. K.
10.1101/2022.09.25.22280081 — Posted: 2022-09-27
Household transmission of SARS-CoV-2 during the Omicron wave in Shanghai, China: a case-ascertained study
Wei, Z., Ma, W., Wang, Z., Li, J., Fu, X., Chang, H., Qiu, Y., Tian, H., Ge, Y., Zhu, Y., Xia, A., Wu, Q., Liu, G., Zhai, X., Zhang, X., Wang, Y., Zeng, M.
10.1101/2022.09.26.22280362 — Posted: 2022-09-27
Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study
Drain, P. K., Dalmat, R. R., HAO, L., Bemer, M. J., Budiawan, E., Morton, J. F., Ireton, R. C., Hsiang, T.-Y., Marfatia, Z., Prabhu, R., Woosley, C., Gichamo, A., Rechkina, E., Hamilton, D., Montano, M., Cantera, J. L., Ball, A., Golez, I., Smith, E., Greninger, A., McElrath, M. J., Thompson, M., Grant, B. D., Meisner, A., Gottlieb, G. S., Gale, M. J.
10.1101/2022.09.26.22280387 — Posted: 2022-09-27
A gene expression-based diagnostic classifier for identification of severe COVID-19 and multisystem inflammatory syndrome in children (MIS-C)
Sotomayor-Gonzalez, A., Loy, C. J., Nguyen, J., Servellita, V., Bhattacharya, S., Lenz, J., Williams, M. E., Suslovic, W., Cheng, A. P., Bliss, A., Saldhi, P., Streithorst, J., Huh, H. J., Foresythe, K., Oseguera, M., de la Cruz, K., Brazer, N., Wood, N., Hsieh, C., Bahar, B., Gliwa, A., Bhakta, K., Perez, M. A., Anderson, E. J., Chahroudi, A., Delaney, M., Butte, A. J., DeBiasi, R., Rostad, C. A., De Vlaminck, I., Chiu, C. Y.
10.1101/2022.09.26.22280395 — Posted: 2022-09-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).